Viral Treatment Boosts Immune Response to Tumor Cells in Mesothelioma Patient
Written by Chrystal Moulton, Staff Writer. Treatment of malignant pleural mesothelioma with genetically engineered virus improves survival time by 18 months in Phase 1 trial.





